Fulcrum Therapeutics (FULC) Operating Margin (2020 - 2024)
Fulcrum Therapeutics (FULC) operating margin from Mar 31, 2020 to Jun 30, 2024. The current Fulcrum Therapeutics (FULC) operating margin is 65.61%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Operating Margin
Quarterly Operating Margin
Annual Operating Margin change of Fulcrum Therapeutics (FULC)
| Year | Operating Margin | Change |
|---|---|---|
| 2024 | -27.38% | -99.30% |
| 2023 | -3938.08% | +121.81% |
| 2022 | -1775.39% | N/A |
| 2022 | -1775.39% | +319.70% |
| 2021 | -423.02% | N/A |
| 2021 | -423.02% | -47.90% |
| 2020 | -811.90% | N/A |
| 2020 | -811.90% | N/A |
Comparison Fulcrum Therapeutics (FULC) operating margin with competitors
Fulcrum Therapeutics (FULC) operating margin is 65.61%.